Your Health. Your Family. Your Choice.
|History of Changes from the VAERS Wayback Machine|
|Vaccination / Manufacturer||Lot / Dose||Site / Route|
|COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH||EJ1685 / 1||AR / IM|
Administered by: Senior Living Purchased by: ??
Symptoms: Cough, Dyspnoea exertional, Lethargy, Oxygen saturation decreased, Unresponsive to stimuli, Decreased appetite, Vital functions abnormal, Hypophagia, SARS-CoV-2 test positive
Life Threatening? No
Birth Defect? No
Permanent Disability? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Other Medications: Citalopram, Divalproex, Levothyroxine
Current Illness: COVID-19
Preexisting Conditions: Dementia, Atrial Fibrillation, Hypothyroidism, Dysphagia
Allergies: Atorvastatin, Donepezil, Corticosteroids
Diagnostic Lab Data:
CDC 'Split Type':
Write-up: Patient began to demonstrate a cough the evening of 1/5/2021, after receiving the COVID-19 vaccine earlier in the afternoon. A rapid COVID-19 test was performed and was positive. She began to demonstrate shortness of breath with exertion on 1/7/21, and lethargy on 1/12/21. Appetite and oral intake began to decline on 1/12/21, and Oxygen saturation dropped on 1/16/21 to 82%, and oxygen was initiated at 3L per nasal cannula. On 1/19/21 at 0414 patient was unresponsive and without vital signs. Orders were for DNR, and CPR was not initiated.
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166